Key facts
as of Sep 2026- It has raised $8.1M; the latest was Accelerator/Incubator in Sep 2025.
- Notable investors include Y Combinator, Google for Startups, Caffeinated Capital, Hub71, Johnson & Johnson Innovation - JLABS — 13 tracked in total.
- 1 institutional filer reports fund marks on Harmonic Discovery across 1 filings.
- Status: Privately Held (backing).
- ·The complete investor list — 13 names
- ·Watchlist + deal alerts for Harmonic Discovery
- ·The full record, as it builds
Recorded secondary trades
No secondary trades in Harmonic Discovery shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
1 filers · latest Jun 20261 SEC-registered fund reported 1 fair-value mark on Harmonic Discovery between Jun 2026 and Jun 2026. Filer-level marks and implied $/share are available to Pro members.
Funding rounds
No funding rounds for Harmonic Discovery are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Harmonic Discovery
Developer of a kinase inhibitor drug platform designed to overcome cancer resistance mechanisms. The company's platform integrates biological screening and medicinal chemistry with computational chemistry, as well as uses structural modeling and machine learning to predict likely clinical resistance mutations and optimize the design of small molecule therapeutics to maintain key targets and avoid harmful off-target interactions, enabling medical practitioners to treat cancer effectively.
- Sector
- Healthcare
- HQ
- New York, NY, United States
- Founded
- 2021
- Employees
- 7
- Website
- harmonicdiscovery.com/
- Ownership
- Privately Held (backing)